Literature DB >> 83648

Differential expression of poly(A)-adjacent sequences of mammary tumor virus RNA in murine mammary cells.

J P Dudley, J M Rosen, J S Butel.   

Abstract

Two DNA probes representative of either the entire mouse mammary tumor virus (MMTV) genome or the poly(A)-adjacent sequences at the 3' end of MMTV RNA were synthesized with calf thymus DNA or oligo(dT) primers, respectively. These probes were used to study the expression of endogenous MMTV sequences in several BALB/c mammary tumor cell lines, in normal lactating BALB/c tissue, and in a cloned C3H tumor cell line. Both probes were characterized with respect to their rates of hybridization with template RNA, their size as determined by alkaline sucrose gradient centrifugation, and the thermal stability of the cDNA.MMTV RNA hybrids. In addition, the ability of the calf thymus oligodeoxy-nucleotide- or oligo(dT)-primed probes to protect (125)I-labeled MMTV RNA or (125)I-labeled poly(A)-adjacent MMTV RNA sequences from S1 nuclease digestion was determined. Hybridization analysis with these two probes indicated that (i) there were approximately 20-fold more oligo(dT)-primed sequences in BALB/c lactating tissue than there were sequences representing the entire genome; (ii) in BALB/c tumor cells, the oligo(dT):random oligonucleotide-primed cDNA sequence ratio was reduced to 4:1; and (iii) in virus-producer C3H tumor cells, there was only a 2-fold excess of oligo(dT)-primed sequences over that observed with a representative cDNA. These results are consistent with the presence of subgenomic viral mRNA species, integration of partial proviral copies, or altered mRNA processing.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83648      PMCID: PMC393062          DOI: 10.1073/pnas.75.12.5797

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Characterization of DNA complementary to nucleotide sequences adjacent to poly(A) at the 3'-terminus of the avian sarcoma virus genome.

Authors:  J Tal; H J Kung; H E Varmus; J M Bishop
Journal:  Virology       Date:  1977-06-01       Impact factor: 3.616

Review 2.  Molecular biology of papovaviruses.

Authors:  G C Fareed; D Davoli
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase.

Authors:  J M Taylor; R Illmensee; J Summers
Journal:  Biochim Biophys Acta       Date:  1976-09-06

4.  Independent polypeptide chain initiation sites for the synthesis of different classes of proteins for an RNA tumor virus: mouse mammary tumor virus.

Authors:  G Schochetman; J Schlom
Journal:  Virology       Date:  1976-09       Impact factor: 3.616

5.  Preparation and preliminary characterization of purified ovalbumin messenger RNA from the hen oviduct.

Authors:  J M Rosen; S L Woo; J W Holder; A R Means; B W O'Malley
Journal:  Biochemistry       Date:  1975-01-14       Impact factor: 3.162

6.  Physical and chemical characterization of purified ovalbumin messenger RNA.

Authors:  S L Woo; J M Rosen; C D Liarakos; Y C Choi; H Busch; A R Means
Journal:  J Biol Chem       Date:  1975-09-10       Impact factor: 5.157

7.  Differences in mouse mammary tumor viruses. Relationship to early and late occurring mammary tumors.

Authors:  J Schlom; D Colcher; W Drohan; R Kettmann; R Michalides; G Vlahakis; J Young
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

8.  Comparison of the growth properties in vitro and transplantability of continuous mouse mammary tumor cell lines and clonal derivatives.

Authors:  J S Butel; J P Dudley; D Medina
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

9.  Steroid induction of mouse mammary tumor virus: effect upon synthesis and degradation of viral RNA.

Authors:  H A Young; T Y Shih; E M Scolnick; W P Parks
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

10.  Quantitation of casein messenger ribonucleic acid sequences using a specific complementary DNA hybridization probe.

Authors:  J M Rosen; S W Barker
Journal:  Biochemistry       Date:  1976-11-30       Impact factor: 3.162

View more
  8 in total

1.  Organization of mouse mammary tumor virus-specific DNA endogenous to BALB/c mice.

Authors:  J C Cohen; J E Majors; H E Varmus
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

2.  The extraction by micrococcal nuclease of glucocorticoid receptors and mouse mammary tumor virus DNA sequences is dissociated.

Authors:  J André; A Raynaud; H Rochefort
Journal:  Nucleic Acids Res       Date:  1980-08-11       Impact factor: 16.971

3.  Restriction endonuclease mapping of the proviral DNA of the exogenous RIII murine mammary tumor virus.

Authors:  P R Etkind; P Szabo; N H Sarkar
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

4.  Quantitative of murine mammary tumor virus-related RNA in mammary tissues of low- and high-mammary-tumor-incidence mouse strains.

Authors:  S L Marcus; S W Smith; N H Sarkar
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

5.  Partial expression of endogenous mouse mammary tumor virus in mammary tumors induced in BALB/c mice by chemical, hormonal, and physical agents.

Authors:  J S Butel; S Dusing-Swartz; S H Socher; D Medina
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

6.  Characterization of a 7,12-dimethylbenz(alpha)anthracene-induced BALB/c mouse mammary tumor epithelial cell line.

Authors:  J P Dudley; D Medina; J S Butel
Journal:  In Vitro       Date:  1980-11

7.  Proteins encoded by the long terminal repeat region of mouse mammary tumor virus: identification by hybrid-selected translation.

Authors:  J Racevskis; O Prakash
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

8.  Identification and characterization of a mouse mammary tumor virus protein uniquely expressed on the surface of BALB/cV mammary tumor cells.

Authors:  B L Slagle; J S Butel
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.